Fresenius Medical…
USUSDFresenius Medical Care AG & Co. KGaA (MI:1FME) — Misc Health and Biotechnology Services. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 5. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- fmcna.com
- Sektor
- Health Care · Misc Health and Biotechnology Services
- Hauptsitz
- BAD HOMBURG, Germany
- CEO
- Helen Giza
- Mitarbeiter
- 125 364
- Gegründet
- 1975
- Börsennotiert Seit
- 01.09.2016 (MI:1FME)
- Ausstehende Aktien
- 266.11 Mio. Stand 2025-12-31
- Streubesitz
- 198.56 Mio.
- Marktkapitalisierung
- 11.86 Mrd. USD
- Insider
- 25.02%
- Institutionelle Anleger
- 52.82%
- Branche (SIC)
- Services-Misc Health & Allied Services, NEC
- Rechtsform
- 6QQB
- ISIN
- DE0005785802
- LEI
- 549300CP8NY40UP89Q40
- P/E
- 11.9
- Ausschüttungsquote
- 42.7%
- FCF
- 1.78 Mrd. EUR
- Ausschüttung / FCF
- 22%
- Schulden
- 11.0 Mrd. EUR3.5 J. FCF
- Dividendenserie
- 28 J.
- Gewinn, FCF und gezahlte Dividenden — für die 12 Monate bis 30.06.2026 (letzter Bericht des Unternehmens).
Beschreibung
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Börsen und Ticker
| Börse | Ticker | Währung | Preis | Typ |
|---|---|---|---|---|
| US USA Stocks | FMCQF OTC | USD | 40.81 -3.68% | Stammaktie |
| LSE London Stock Exchange | 0H9X IOB | EUR | 44.12 +0.00% | Stammaktie |
| MI Borsa Italiana (Milan) | 1FME zusätzlich | EUR | 39.5 +0.69% | Stammaktie |
| VI Vienna Stock Exchange | FME zusätzlich | EUR | 40.31 +0.12% | Stammaktie |
| XETRA Xetra | FME primär | EUR | 39.8 -1.68% | Stammaktie |
Dividenden
Fresenius Medical Care AG & Co. KGaA (1FME) zahlt einmal jährlich Dividenden. Pro Jahr (12 Monate bis einschließlich der zuletzt angekündigten Zahlung): 1.49 EUR pro Aktie (Zahlungen: 1). Das entspricht etwa 3.77% des aktuellen Aktienkurses. Basierend auf der Zahlungshistorie wird der nächste Ex-Dividenden-Tag um den 28.05.2027 erwartet. Ununterbrochene Dividendengeschichte: 28 Jahre.
| Ex-tag | Auszahlung | Betrag | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-05-22 | 2026-05-27 | 1.4900 EUR | 3.9/3.9 % | jährlich | MI:1FME |
| 2025-05-23 | 2025-05-27 | 1.4400 EUR | 2.7/2.7 % | jährlich | MI:1FME |
| 2024-05-17 | 2024-05-22 | 1.1900 EUR | 2.9/2.9 % | jährlich | MI:1FME |
| 2023-05-17 | — | 1.1200 EUR | 2.6/2.6 % | jährlich | MI:1FME |
| 2022-05-13 | — | 1.3500 EUR | 2.4/2.4 % | jährlich | MI:1FME |
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| Dodge & Cox Funds-Dodge… | 5.61% | 13.75 Mio. | 2026-06-30 |
| Artisan Partners Funds I… | 2.68% | 6.58 Mio. | 2026-06-30 |
| VANGUARD STAR FUNDS-Vang… | 1.25% | 3.07 Mio. | 2026-07-31 |
| Dodge & Cox Funds-Dodge… | 1.06% | 2.61 Mio. | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.8% | 1.95 Mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.59% | 1.44 Mio. | 2026-08-31 |
| Columbia Funds Series Tr… | 0.57% | 1.4 Mio. | 2026-05-31 |
| Bridge Builder Trust-Bri… | 0.55% | 1.35 Mio. | 2026-06-30 |
| SEI INSTITUTIONAL INVEST… | 0.52% | 1.27 Mio. | 2026-07-31 |
| Datum One Series Trust-B… | 0.44% | 1.08 Mio. | 2026-06-30 |
| Pacer Advisors, Inc. | 0.16% | 387 540 | 2026-06-30 |
| Generali Investments Cee… | 0% | 9 100 | 2026-06-30 |
| Paradigm Asset Managemen… | 0% | 697 | 2026-06-30 |
